Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 117,404 | 94,370 | 278,562 | 158,823 | 152,000 |
| Depreciation Amortization | 170,362 | 87,355 | 301,760 | 206,923 | 123,595 |
| Other Working Capital | 149,253 | 45,359 | -109,388 | -31,173 | -37,430 |
| Other Operating Activity | -8,686 | -10,283 | -49,413 | -20,258 | -15,865 |
| Operating Cash Flow | $428,332 | $216,802 | $421,521 | $314,315 | $222,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,950 | -2,499 | -38,380 | -16,003 | -6,745 |
| Net Acquisitions | N/A | N/A | -1,599,422 | -1,568,892 | -1,611,295 |
| Purchase Sale Intangibles | -68,649 | -69,096 | -427,745 | -398,860 | -380,000 |
| Other Investing Activity | -68,649 | -69,096 | -427,745 | -398,861 | -380,095 |
| Investing Cash Flow | $-73,599 | $-71,595 | $-2,065,547 | $-1,983,755 | $-1,998,135 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -353,893 | N/A | 3,383,107 | 1,051,725 | 1,724,060 |
| Debt Repayment | N/A | -169,136 | -2,322,420 | N/A | N/A |
| Common Stock Issued | 8,780 | 5,286 | 17,068 | 12,118 | 11,020 |
| Other Financing Activity | -19,801 | -15,376 | 526,477 | 542,883 | -11,400 |
| Financing Cash Flow | $-364,914 | $-179,227 | $1,604,232 | $1,606,725 | $1,723,680 |
| Exchange Rate Effect | -1,494 | -2,306 | -3,301 | -463 | -2,090 |
| Beginning Cash Position | 84,434 | 86,874 | 128,342 | 125,893 | 129,295 |
| End Cash Position | 72,759 | 50,645 | 85,247 | 62,715 | 75,050 |
| Net Cash Flow | $-11,675 | $-36,230 | $-43,095 | $-63,178 | $-54,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | 428,332 | 216,802 | 421,521 | 314,315 | 222,300 |
| Capital Expenditure | -4,950 | -2,499 | -38,380 | -16,003 | -6,745 |
| Free Cash Flow | 423,382 | 214,303 | 383,141 | 298,313 | 215,555 |